340B Drug Pricing Program
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023. These increases led to $815 million incremental added costs for U.S. payers.
AHA urges 340B members to complete a brief survey to help the association understand how a 340B rebate model — such as the one Johnson & Johnson sought to implement this year — would impact 340B member hospitals.
As the largest rural hospital in Eastern Kentucky, UK St. Claire is part of an integrated health system serving as the primary provider across 11 counties in the region and caring for 170,000 patients annually.
340B Advocacy Alliance Bulletin for December 3, 2024.
AHA 340B Advocacy Alliance Bulletin - December 3, 2024.
The AHA Nov. 15 filed friend-of-the-court briefs in the U.S. Court of Appeals for the 5th Circuit in support of an earlier denial by the U.S. District Court for the Southern District of Mississippi of preliminary injunctions sought by Novartis and PhRMA against enforcement of the state's 340B…
AHA, others challenge Novartis in court filings to defend Mississippi’s 340B contract pharmacy law .
AHA, others challenge PhRMA in court filings to defend Mississippi’s 340B contract pharmacy law.
Johnson & Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit…
Johnson & Johnson yesterday filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit…